John Philip Bamforth - 11 Jun 2026 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Jun 2026, 17:52:30 UTC
Prior SEC filing
16 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John Philip Bamforth by Dale A. Sander as Attorney-in-Fact

Key filing fact

John Philip Bamforth filed Form 4 for Humacyte, Inc. (HUMA) on 12 Jun 2026.

Key facts

  • This page summarizes John Philip Bamforth's Form 4 filing for Humacyte, Inc. (HUMA).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 12 Jun 2026, 17:52.

Change

  • Previous filing in this sequence was filed on 16 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002026341 Primary reporting owner

Bamforth John Philip

Relationship
Director
Address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Signature
/s/ John Philip Bamforth by Dale A. Sander as Attorney-in-Fact
Signature date
12 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HUMA transaction Derivative

Stock Options (right to buy)

Award

Transaction value
Shares
+80,000
Change %
Price
$0.000000*
Shares after
80,000
Date
11 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
80,000
Exercise price
$1.08
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .